Bayforest Capital’s Medical Properties Trust MPT Stock Holding History

Bayforest Capital’s Portfolio MPT Stock Details MPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-69,175	Closed	-$417K	–	858
2025 Q1	$417K	Buy	+69,175	New	+$350K	0.18%	201

Other funds holding MPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bayforest Capital's MPT Position: Q2 2025 in Review

Bayforest Capital sold out of Medical Properties Trust (MPT) in Q2 2025, closing a stake of 69,175 shares — an estimated $417K sold.

Bayforest Capital first reported a position in MPT in Q1 2025 and held it in 1 quarter. The position peaked at $417K in Q1 2025. 475 funds tracked by Wall St. Rank hold MPT as of Q2 2025.

Bayforest Capital reported no remaining Medical Properties Trust position as of Q2 2025 after selling out during the quarter.
Bayforest Capital sold 69,175 Medical Properties Trust shares in Q2 2025, an estimated $417K.
Bayforest Capital first reported a position in Medical Properties Trust in Q1 2025 and held it in 1 quarter.
Bayforest Capital's Medical Properties Trust position peaked at $417K in Q1 2025.
475 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2025.

Based on Bayforest Capital's 13F filing for Q2 2025, filed 28 Jul 2025.